ABSTRACT BACKGROUND Infections are the most common noncardiac complication after cardiac surgery, but their incidence
DESIGN. For this study, we assumed that the 60-day incidence of major infections was approximately 4% to 5% (3, 4) . We targeted a minimum sample size of 5,000 patients to obtain at least 200 patients with major infections. This sample size was based not on explicit statistical criteria, but on acquiring an adequate number of events (at least 10 per variable) to ensure stability of coefficient estimates in our models (8, 9) . Patients were followed for up to 65 days after surgery with 2 planned postdischarge assessments at 30 and 60 days after surgery; the last date of follow-up was November 29, 2010 (Online Fig. 1 ). Data were transmitted electronically to the data coordinating center, which conducted electronic monitoring and sent monitors to the sites to review data quality (Online Table 1 ).
An independent event adjudication committee con- Crude risk ratios describe univariate associations between these variables and first major infection.
To account for the effect of mortality on infection risk in the multivariable analysis, we fitted competing risk models with death and infection as competing events (11) . We fit multivariable models for infection in 2 stages. First, we used proportional hazards regression to select a set of patient-and procedure-related risk factors associated (at p < 0. 
FREQUENCY AND CHARACTERISTICS OF INFECTIONS.
A total of 237 patients (4.6%) experienced 301 major infections (rate/patient month: 0.028; Online *Denominator for patients with a deep surgical site infection is patients having a sternotomy (n ¼ 4,669). †Denominator for pocket infection is patients who had left ventricular assist device placed, replaced, or removed for heart transplant (n ¼ 86).
Gram-positive, and 123 (47%) were Gram-negative. Table 4 . Tables 1 and 4 . Table 4 ). Mortality risk for men was half that of women (HR: 0.49; 95% CI: 0.33 to 0.72). The 65-day mortality rate for infected patients was 5% and 0.7% for noninfected patients. The 30-day readmission rate was 14%, while the overall readmission rate in this cohort was 19%. Infections accounted for 16% of all readmissions.
CEPH ¼ cephalosporin; PRBC ¼ packed red blood cells; other abbreviations as in

DISCUSSION
The findings from this prospective cohort study of more than 5,000 patients challenge the common perception that SSIs, particularly deep sternal site infections, are the most important infections acquired by patients undergoing cardiac surgery.
Instead, we found that pneumonia, bloodstream infections, and C. difficile colitis accounted for 79% of all major post-operative infections. Moreover, these major infections occurred later than expected, with 45% becoming evident only after hospital discharge.
These findings are particularly important given the prevalence of infections in this population (12% of patients experienced infections, with 4.6% being major), the high mortality risk (10-fold) for major infections, and their impact on readmissions.
To assess QI strategies, we examined baseline predictors for the full range of cardiac surgery procedures, including the nature of the procedure itself.
Patient-and procedure-related factors associated with infection risk are similar to those found in studies of infections after CABG and in ICU patients (3, 12) . Contrary to previous observations, this study did not find that obesity, diabetes, or urgent surgery were independent risk factors for infection in the multivariable analysis (4, 12) .
Several management practices were associated with post-operative infection risk, including the type and duration of antibiotic prophylaxis. The Society of Thoracic Surgeons (STS) guidelines recommend using a first-generation cephalosporin, and if patients are beta-lactam or penicillin allergic, using vancomycin with additional Gram-negative coverage (13, 14) .
In this study, second-generation cephalosporins (AE vancomycin) were more commonly used than first- 
